Vitamin D supplementation: What is right?

Clinical Cases in Mineral and Bone Metabolism

Volumn 3, Issue 1, 2006, Pages 71-75

  Alvarez Hernández, Daniel ^a   Gómez Alonso, Carlos ^a   Cannata Andía, Jorge B ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Calcidiol; Calcitriol; Food fortification; Vitamin D status; Vitamin D supplementation

Indexed keywords

CALCIFEDIOL; CALCITRIOL; CALCIUM; COLECALCIFEROL; ERGOCALCIFEROL; OXYGENASE; VITAMIN D; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR;

BONE MINERALIZATION; CEREAL; DAIRY PRODUCT; DOSE RESPONSE; DRUG DOSE REGIMEN; FOOD AND DRUG ADMINISTRATION; FOOD INTAKE; FRAGILITY FRACTURE; HEMODIALYSIS; HUMAN; METABOLIC BONE DISEASE; METABOLITE; MILK; OSTEOMALACIA; OSTEOPOROSIS; PUBLIC HEALTH; RICKETS; RISK FACTOR; SECONDARY HYPERPARATHYROIDISM; SHORT SURVEY; SUN EXPOSURE; TARGET ORGAN; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D INTOXICATION; VITAMIN D METABOLISM; VITAMIN SUPPLEMENTATION;

EID: 33750920084     PISSN: 17248914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (54)

1. Holick M. Vitamin D: Photobiology, Metabolism, and Clinical Applications. In de Groot L, Besser H, Burger H (eds). Endocrinology, WB Saunders: Philadelphia, 1995, pp 990-1013.
2. McKenna MJ. Differences in vitamin D status between countries in young adults and the elderly. Am J Med. 1992;93:69-77.
3. Bouillon R, Carmeliet G, Daci E, et al. Vitamin D metabolism and action. Osteoporos Int. 1998;8(Suppl 2):S13-19.
4. Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol. 2005;289:F8-28.
5. Zehnder D, Bland R, Walker EA, et al. Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in the human kidney. J Am Soc Nephrol. 1999;10:2465-2473.
6. Gomez C, Naves ML, Barrios Y, et al. Vitamin D receptor gene polymorphisms, bone mass, bone loss and prevalence of vertebral fracture: differences in postmenopausal women and men. Osteoporos Int. 1999;10:175-182.
7. Morrison NA, Qi JC, Tokita A, et al. Prediction of bone density from vitamin D receptor alleles. Nature. 1994;367:284-287.
8. Salamone LM, Ferrell R, Black DM, et al. The association between vitamin D receptor gene polymorphisms and bone mineral density at the spine, hip and whole-body in premenopausal women. Osteoporos Int. 1996;6:63-68.
9. Riggs BL, Nguyen TV, Melton LJ, 3rd, et al. The contribution of vitamin D receptor gene alleles to the determination of bone mineral density in normal and osteoporotic women. J Bone Miner Res. 1995;10:991-996.
10. Gross C, Eccleshall TR, Malloy PJ, et al. The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. J Bone Miner Res. 1996; 11:1850-1855.
11. Uitterlinden AG, Pols HA, Burger H, et al. A large-scale population-based study of the association of vitamin D receptor gene polymorphisms with bone mineral density. J Bone Miner Res. 1996;11:1241-1248.
12. Torres A, Machado M, Concepcion MT, et al. Influence of vitamin D receptor genotype on bone mass changes after renal transplantation. Kidney Int. 1996;50:1726-1733.
13. Ames SK, Ellis KJ, Gunn SK, et al. Vitamin D receptor gene Fok1 polymorphism predicts calcium absorption and bone mineral density in children. J Bone Miner Res. 1999;14:740-746.
14. Dawson-Hughes B, Harris SS, Finneran S. Calcium absorption on high and low calcium intakes in relation to vitamin D receptor genotype. J Clin Endocrinol Metab. 1995;80:3657-3661.
15. Gennari L, Becherini L, Masi L, et al. Vitamin D receptor genotypes and intestinal calcium absorption in postmenopausal women. Calcif Tissue Int. 1997;61:460-463.
16. Ferrari S, Rizzoli R, Chevalley T, et al. Vitamin-D-receptor-gene polymorphisms and change in lumbar-spine bone mineral density. Lancet. 1995;345:423-424.
17. Graafmans WC, Lips P, Ooms ME, et al. The effect of vitamin D supplementation on the bone mineral density of the femoral neck is associated with vitamin D receptor genotype. J Bone Miner Res. 1997;12:1241-1245.
18. Matsuyama T, Ishii S, Tokita A, et al. Vitamin D receptor genotypes and bone mineral density. Lancet. 1995;345:1238-1239.
19. Cannata-Andia JB, Gomez Alonso C. Vitamin D deficiency: a neglected aspect of disturbed calcium metabolism in renal failure. Nephrol Dial Transplant. 2002;17:1875-1878.
20. Fournier A, Fardellone P, Achard JM, et al. Importance of vitamin D repletion in uraemia. Nephrol Dial Transplant. 1999;14:819-823.
21. Heaney RP, Davies KM, Chen TC, et al. Human serum 25- hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003;77:204-210.
22. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999;69:842-856.
23. Lips P, Chapuy MC, Dawson-Hughes B, et al. An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporos Int. 1999;9:394-397.
24. Vieth R. Problems with direct 25-hydroxyvitamin D assays, and the target amount of vitamin D nutrition desirable for patients with osteoporosis. Osteoporos Int. 2000;11:635-636.
25. McKenna MJ, Freaney R. Secondary hyperparathyroidism in the elderly: means to defining hypovitaminosis D. Osteoporos Int. 1998;8(Suppl 2):S3-6.
26. Scharla SH. Prevalence of subclinical vitamin D deficiency in different European countries. Osteoporos Int. 1998;8(Suppl 2):S7-12.
27. Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med. 1998;338:777-783.
28. van der Wielen RP, Lowik MR, van den Berg H, et al. Serum vitamin D concentrations among elderly people in Europe. Lancet. 1995;346:207-210.
29. Lips P, Duong T, Oleksik A, et al. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab. 2001;86:1212-1221.
30. Passeri G, Pini G, Troiano L, et al. Low vitamin D status, high bone turnover, and bone fractures in centenarians. J Clin Endocrinol Metab. 2003;88:5109-5115.
31. Heaney RP. Vitamin D: how much do we need, and how much is too much? Osteoporos Int. 2000;11:553-555.
32. Dawson-Hughes B, Heaney RP, Holick MF, et al. Estimates of optimal vitamin D status. Osteoporos Int. 2005;16:713-716.
33. Management of Osteoporosis. http://www.sing.ac.uk/guidelines/ fulltext/71/index.html 2003; Guide line 71.
34. Gomez-Alonso C, Naves-Diaz ML, Fernandez-Martin JL, et al. Vitamin D status and secondary hyperparathyroidism: the importance of 25-hydroxyvitamin D cut-off levels. Kidney Int. Suppl 2003:S44-48.
35. Cunningham J, Makin H. How important is vitamin D deficiency in uraemia? Nephrol Dial Transplant. 1997;12:16-18.
36. Ghazali A, Fardellone P, Pruna A, et al. Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol? Kidney Int. 1999;55:2169-2177.
37. Gomez Alonso C, Naves Diaz M, Rodriguez Garcia M, et al. [Review of the concept of vitamin D "sufficiency and insufficiency"]. Nefrologia 2003;23(Suppl 2):73-77.
38. Gomez Alonso C, Mallofre C, Tomas X. [Pain and muscle weakness of the pelvic waist of 2 years' duration in a 39-year-old woman]. Med Clin (Bare). 2003;121:109-116.
39. Heckmatt JZ, Peacock M, Davies AE, et al. Plasma 25-hydroxyvitamin D in pregnant Asian women and their babies. Lancet. 1979; 2:546-548.
40. Tangpricha V, Koutkia P, Rieke SM, et al. Fortification of orange juice with vitamin D: a novel approach for enhancing vitamin D nutritional health. Am J Clin Nutr, 2003;77:1478-1483.
41. British Pediatric Association: Hypercalcaemia in infants and vitamin D. Br Med J. 1956;2:149-158.
42. Murphy SC, Whited LJ, Rosenberry LC, et al. Fluid milk vitamin fortification compliance in New York State. J Dairy Sci. 2001;84: 2813-2820.
43. Heaney RP. Vitamin D, nutritional deficiency, and the medical paradigm. J Clin Endocrinol Metab. 2003;88:5107-5108.
44. Trang HM, Cole DE, Rubin LA, et al. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr. 1998;68:854-858.
45. Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA. 2005;293:2257-2264.
46. Larrosa M, Gratacos J, Vaqueiro M, et al. [Prevalence of hypovitaminosis D in elderly institutionalized residents: influence of a substitutive treatment]. Med Clin (Barc). 2001;117:611-614.
47. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes Food and Nutrition Board Institute of Medicine 1997: Vitamin D. In Press NA (eds). Dietary refence intakes of Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride, Washington (DC), 1999, pp 250-287.
48. Scientific Committee on Food. Opinion of the scientific committee on food upper intake level of vitamin D (expressed on 4 December 2002) [online]. http://europa.eu.int/comm/food/fs/sc/scf/out157_en. pdf [accessed 8 October 2004].
49. United States Food and Drug Administration. Reference daily indtakes, recommended dietary allowances [online]. http://www. fda.gov/fdac/special/ foodlabel/rditabl.html [accessed 27 July 2004].
50. Holick MF, Siris ES, Binkley N, et al. Prevalence of Vitamin D Inadequacy Among Postmenopausal North American Women Receiving Osteoporosis Therapy. Obstet Gynecol Surv. 2005;60: 658-659.
51. Jacobus CH, Holick MF, Shao Q, et al. Hypervitaminosis D associated with drinking milk. N Engl J Med. 1992;326:1173-1177.
52. Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet. 1998;351:805-806.
53. Vieth R, Chan PC, MacFarlane GD. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr. 2001;73:288-294.
54. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ. 2003;326:469.